Patra NeurosurgicalPatient education

Procedure

Microvascular decompression

Surgery that moves a blood vessel off the trigeminal nerve to stop the pain of trigeminal neuralgia. It is for selected people whose pain is not controlled by medicine.

How this page was written
Compiled from the sources cited on the page, with AI drafting assistance
Clinical review
Not individually reviewed by a clinician. How pages are written
Last updated
November 17, 2026

General information, not medical advice. In an emergency call 911. Full disclaimer

What it does

In trigeminal neuralgia, a blood vessel often presses on the nerve root near the brainstem. Microvascular decompression (MVD) moves the vessel away from the nerve through an opening in the skull. [1] [2] Unlike needle procedures, the goal is to stop the pain without making the face numb. [2]

When it is considered

What matters most in the decision

MVD gives the longest pain relief of the surgical options, but it is the most invasive. [2] [4] You are weighing a good chance of lasting pain relief without medicine against the risks of brain surgery.

Who may do better. In a review of 46 studies, pain freedom was more likely with pain for 5 years or less, with an artery (not a vein) pressing on the nerve, and with mainly sharp, shock-like pain. [5] [1]

Who may not be a good candidate.

Preparation and what happens

You will have high-detail MRI before surgery. [3] The surgeon makes an opening in the skull behind the ear and gently moves the vessel off the nerve. [1] [8] In one study, people usually stayed in the hospital 2 to 3 days. [9]

Expected benefits

Risks and complications

Pain can come back. In the long-term study, pain returned in 30 out of 100 people, mostly in the first 2 years. About 11 out of 100 had a second operation. After 10 years, the chance of pain returning was less than 1 out of 100 per year. [10]

Serious or lasting risks. Studies report very different rates. Ask your surgeon for their own results.

Risk One center, 1,185 people, from records [10] 115 people checked by independent assessors [9]
Hearing loss on the same side About 1 out of 100 About 10 out of 100 (lasting)
Severe facial numbness Not reported About 7 out of 100 (lasting)
Stroke About 1 out of 1,000 (brainstem) About 6 out of 100
Death About 2 out of 1,000 Not reported

In the independent study, 7 out of 100 also had lasting trouble with balance. About 29 out of 100 had a major complication in the first year, and about half of these got better by 2 years. [9]

Other risks include a spinal fluid leak, infection, facial weakness, and double vision. [2] [1] We did not find one dependable rate for spinal fluid leak.

Alternatives

Recovery and follow-up

If pain returns after MVD, repeat MVD, needle procedures, and radiosurgery are all options. In a review of 886 people with pain after a first MVD, long-term relief was about 82 out of 100 after a second MVD, 68 out of 100 after a needle procedure, and 67 out of 100 after radiosurgery. [11] Any change in medicine should come from your treating team. Recovery varies. Follow the discharge instructions from your own team.

Questions to ask

  1. Does my MRI clearly show a vessel pressing on the nerve?
  2. How many of these operations do you do, and what are your hearing loss and stroke rates?
  3. What is my chance of being pain free off medicine?
  4. If the pain comes back, what would we do next?

Sources

  1. Trigeminal Neuralgia. American Association of Neurological Surgeons (AANS). Published April 10, 2024. Open source
  2. Trigeminal Neuralgia. National Institute of Neurological Disorders and Stroke (NINDS). Open source
  3. Bendtsen L, Zakrzewska JM, Abbott J, et al. European Academy of Neurology guideline on trigeminal neuralgia. Eur J Neurol. 2019;26(6):831-849. Published April 8, 2019. Open source
  4. Cruccu G, Gronseth G, Alksne J, et al. AAN-EFNS guidelines on trigeminal neuralgia management. Eur J Neurol. 2008;15(10):1013-1028. Published August 21, 2008. Open source
  5. Holste K, Chan AY, Rolston JD, Englot DJ. Pain outcomes following microvascular decompression for drug-resistant trigeminal neuralgia: a systematic review and meta-analysis. Neurosurgery. 2020;86(2):182-190. Published February 1, 2020. Open source
  6. Sultan H, Sabahi M, Gholamshahi H, et al. Long-term outcomes of microvascular decompression for trigeminal neuralgia in multiple sclerosis: a systematic review and meta-analysis. J Neurosurg. 2025;144(5):1122-1133. Published December 5, 2025. Open source
  7. Khaboushan AS, Maroufi SF, Jarrah N, et al. Comparison of stereotactic radiosurgery and rhizotomy for trigeminal neuralgia: a systematic review and meta-analysis. Neurosurg Rev. 2025;48(1):613. Published August 20, 2025. Open source
  8. Zagzoog N, Attar A, Takroni R, Alotaibi MB, Reddy K. Endoscopic versus open microvascular decompression for trigeminal neuralgia: a systematic review and comparative meta-analysis. J Neurosurg. 2019;131(5):1532-1540. Published December 7, 2018. Open source
  9. Andersen ASS, Heinskou TB, Rochat P, et al. Microvascular decompression in trigeminal neuralgia - a prospective study of 115 patients. J Headache Pain. 2022;23(1):145. Published November 19, 2022. Open source
  10. Barker FG, Jannetta PJ, Bissonette DJ, Larkins MV, Jho HD. The long-term outcome of microvascular decompression for trigeminal neuralgia. N Engl J Med. 1996;334(17):1077-1083. Published April 25, 1996. Open source
  11. Baig Mirza A, Fayez F, Georgiannakis A, et al. Recurrent trigeminal neuralgia following MVD: a meta-analysis of second-line treatment strategies. Neurosurg Focus. 2025;59(3):E16. Published September 1, 2025. Open source